Conatus Pharmaceuticals Inc. (CNAT)

Conatus Pharmaceuticals Inc. (CNAT)

$0.77 USD

0.01 (1.09%)

Updated Jun 14 6:55pm

Add CNAT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 322 in Biotech

See all “A” rated Strong Buy stocks

CNAT Daily Price Range
CNAT 52-Week Price Range

CNAT News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All CNAT News

Conatus Pharmaceuticals Inc. (CNAT) Company Bio

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. The company was founded in 2005 and is based in San Diego, California.

CNAT Stock Chart More Charts

CNAT Price/Volume Stats

Current price $0.77
Prev. close $0.76
Day low $0.72
Day high $0.78
50-day MA $0.88
200-day MA $2.68
52-week high $6.74
52-week low $0.69
Volume 121,000
Avg. volume 779,987
Dividend yield N/A
Market Cap 25.54M

CNAT Social Stream

Loading social stream, please wait...

View Full CNAT Social Stream

CNAT Returns

1-mo -10.47%
3-mo -73.17%
6-mo -37.40%
1-year -85.79%
3-year -59.90%
5-year -90.43%
YTD -55.49%
2018 -62.55%
2017 -12.33%
2016 82.99%
2015 -58.86%
2014 8.53%
Page generated in 0.4388 seconds.